Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases

Phase II/III Study of Radiofrequency Ablation Combined with Cytokine-Induced Killer Cells Treating Colorectal Liver Metastases

Purpose: This phase II/III, non-randomized clinical trial aimed to determine the efficacy and safety of the combination of radiofrequency ablation (RFA) and cytokine-induced killer (CIK) cells transfusion for patients with colorectal liver metastases (CRLMs). Experimental Design: A total of 60 eligi...

Full description

Bibliographic Details
Main Authors: Xiaodong Li, Xichao Dai, Liangrong Shi, Yong Jiang, Xuemin Chen, Lujun Chen, Jiemin Zhao, Weiguang Qiang, Jun Wu, Mei Ji, Jingting Jiang, Changping Wu
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2016-11-01
Series:Cellular Physiology and Biochemistry
Subjects:
Radiofrequency ablation
Cytokine-induced killer cells
Progression-free survival
Overall survival
Colorectal liver metastases
Online Access:http://www.karger.com/Article/FullText/452531

Internet

http://www.karger.com/Article/FullText/452531

Similar Items